Nimble Diagnostics
PrivateLast Round
Series A
Apr 1, 2025
Total Funding Raised
$3.71M
Company Overview
Nimble Diagnostics operates in Healthcare & Life Sciences and is based in Badalona. Its latest recorded funding round was a Grant round in October 2023.
Nimble Diagnostics is a medical technology company developing a non-invasive, microwave-based device to monitor patients with implanted stents.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nimble Diagnostics Comparables
Compare Nimble Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VesselSens GmbH | 83% | |
| Sensydia | 69% | |
| LUMA Vision | 69% |
For institutional investors. Book with your work email.
Nimble Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 1, 2025 | ||||
| Grant | Oct 31, 2023 | ||||
| Seed | Jan 15, 2023 |
For institutional investors. Book with your work email.
Nimble Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Grow Venture Partners | Seed |
| Namarel Ventures | Seed |
| Inveniam Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
$14M round completed.
- Oct 31, 2023
Secured $2.63M from the European Innovation Council
For institutional investors. Book with your work email.
Nimble Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nimble Diagnostics's valuation, stock price, and market status.
Is Nimble Diagnostics a public or private company?
Nimble Diagnostics is a private company.
What is the current stock price of Nimble Diagnostics?
Nimble Diagnostics is a private company, so its shares have no public market price. Caplight tracks Nimble Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nimble Diagnostics worth (valuation)?
Valuation information for Nimble Diagnostics is not publicly available.
Can I buy Nimble Diagnostics stock?
Nimble Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nimble Diagnostics's last funding round?
Nimble Diagnostics's most recent funding round was Series A on April 1, 2025.
Who are the main investors in Nimble Diagnostics?
Key investors in Nimble Diagnostics include Grow Venture Partners.
Will Nimble Diagnostics IPO soon?
No public IPO plans have been announced for Nimble Diagnostics.
How can I track Nimble Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Nimble Diagnostics's shares on secondary markets.